Acne Keloidalis Nuchae Successfully Treated with Halobetasol 0.01% and Tazarotene 0.045%

Olga Marushchak, Kathryn Jayne Tan, Maria Rosa Noliza Encarnacion, Loren Clark, Alexandra Golant

Research output: Contribution to journalArticlepeer-review

Abstract

Acne keloidalis nuchae (AKN) is an idiopathic chronic inflammatory condition that predominantly affects African-American men and presents with follicular papules, pustules and plaques, which may eventually lead to keloid-like scarred lesions, fibrotic plaques, abscesses, sinuses, and alopecia. Conventional treatment approach focuses on avoidance of exacerbation factors, utilization of topical and oral antibiotics, and decreasing inflammation with intralesional steroids. This is the first case showing successful treatment of AKN with halobetasol 0.01% and tazarotene 0.045% lotion. Although topical steroids and topical retinoids have been used as treatment options, there are no published data supporting the use of their fixed combination in patients with AKN.

Original languageEnglish
Pages (from-to)311-314
Number of pages4
JournalSKIN: Journal of Cutaneous Medicine
Volume6
Issue number4
DOIs
StatePublished - Jul 2022

Fingerprint

Dive into the research topics of 'Acne Keloidalis Nuchae Successfully Treated with Halobetasol 0.01% and Tazarotene 0.045%'. Together they form a unique fingerprint.

Cite this